skip to main content

H.R. 853 (117th): Closing Loopholes for Orphan Drugs Act

Compare this bill to another bill:

React to this bill with an emoji

(About Ads | Hide These Ads)

The text of the bill below is as of Feb 4, 2021 (Introduced). The bill was not enacted into law.

I

117th CONGRESS

1st Session

H. R. 853

IN THE HOUSE OF REPRESENTATIVES

February 4, 2021

(for himself and Mr. McKinley) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.

1.

Short title

This Act may be cited as the Closing Loopholes for Orphan Drugs Act.

2.

Limiting the orphan drug exclusion under 340B drug discount program

(a)

In general

Section 340B(e) of the Public Health Service Act (42 U.S.C. 256b(e)) is amended by inserting before the period at the end the following: when transferred, prescribed, sold, or otherwise used for the rare condition or disease for which such drug is so designated.

(b)

Effective date

The amendment made by subsection (a) shall apply with respect to covered outpatient drugs purchased on or after the date of the enactment of this Act.